Recombinetics is a recognized leader in animal gene editing for biomedical research and animal agriculture. We offer custom gene edited swine models for translational preclinical research which promises to expedite the regulatory preclinical path, as well as supplement or reduce the reliance on nonhuman primates. Our mission is to elevate biomedical innovation through services, products, and expertise that is built on relationships and integrity.
clinical trials for cell and gene therapies in past 5 years
of all clinical trials fail
Smallholders need more efficient animals to produce healthy protein
We will be attending several conferences in 2025 to discuss our reporter swine models and customizable cancer models:
Nucleic Acid Therapies – Cold Spring Harbor, March 19-22
Gene Therapy Summit for Rare Disorders – Boston, March 22-27
LNP Formulation and Process – Boston, April 14-16
AACR – Chicago, April 25-30
ASGCT – New Orleans, May 13-17
BIO – Boston, June 16-19
We’d love to learn more about your preclinical needs!
We use state-of-the-art breeding methods to precisely deliver traits that improve the health, welfare and sustainability of food animals to feed a hungry world while protecting the environment.
